Study Notes on Mood Stabilizing Agents and Antidepressants

Learning Objective: Mechanism of Action, Adverse Effects, and Clinical Considerations of Mood Stabilizing Agents

Lithium Carbonate

Mechanism of Action

  • The precise mechanism of action of lithium carbonate is not fully understood.

  • It is hypothesized that lithium increases the action of the amine reuptake pump.

  • By enhancing this pump, lithium inhibits the release of noradrenaline, leading to a depletion of neurotransmitters within the synapse.

Common Adverse Effects

  • Gastrointestinal Issues: Gastrointestinal irritation.

  • Neurological Effects: Tremors, muscle weakness, and polyuria (increased urination).

  • Potential Symptoms of Excessive Lithium:

    • Ringing in the ears (tinnitus)

    • Blurred vision

    • Difficulty walking

    • Muscle twitching

    • Altered consciousness

Serious Adverse Effects

  • Hypothyroidism: Lithium can cause functional issues related to the thyroid gland.

  • Kidney Issues: Lithium may adversely affect kidney function.

  • Increased Thirst: Known as polydipsia, it refers to an excessive thirst that accompanies polyuria.

Clinical Considerations

  • Narrow Therapeutic Range: Lithium has a narrow therapeutic index, meaning the difference between an effective and a toxic dose is small.

  • Drug Interactions: Lithium has many interactions with medications, particularly non-steroidal anti-inflammatory drugs (NSAIDs).

  • First-Line Treatment: Lithium is considered the first-line agent for treating and preventing acute mania, especially in bipolar disorder.

Anti-Seizure Agents

  • Common Medications:

    • Carbamazepine

    • Sodium valproate

    • Lamotrigine

    • Clonazepam

  • Mechanism of Action: The exact mechanisms for these drugs in treating bipolar disorder are not fully understood, but they are known to stabilize the erratic firing patterns of the neurons that regulate mood.

  • Clinical Considerations:

    • Monitoring of electrolytes and liver function is crucial due to the impact these drugs may have on blood chemistry.

    • A full blood examination is necessary to track potential adverse effects and interactions.

  • Usage Protocol: These agents are typically used when lithium is ineffective, contraindicated, or not preferred.

Depression Overview

Definition

  • Depression: A profound state of sadness characterized by complex interactions within various brain regions.

Theoretical Framework

  • Biogenic Amine Hypothesis: This hypothesis posits that depression is linked to neurotransmitters such as adrenaline and serotonin, playing a key role in developing antidepressants.

Antidepressant Groups

  • Categories of Antidepressants:

    • Tricyclic Antidepressants (TCAs):

    • Selective Serotonin Reuptake Inhibitors (SSRIs):

    • Non-Selective Irreversible Monoamine Oxidase Inhibitors (MAOIs):

    • Reversible Inhibitors of Monoamine Oxidase:

    • Serotonin-Noradrenaline Reuptake Inhibitors (SNRIs):

    • Selective Noradrenaline Reuptake Inhibitors (NARIs):

    • Melatonin Agonists:

Antidepressant Efficacy

  • It generally takes three to four weeks for an antidepressant to show effects. In instances where a patient does not respond to a particular antidepressant, they should be switched to another antidepressant following a washout period.

Conclusion

  • The primary medication groups used for mood stabilization include lithium carbonate and anti-seizure medications. Due to lithium's low therapeutic index, it requires careful monitoring of blood levels to ensure safety and efficacy.

References

  • Reference list provided by the presenter.

Thank you for watching.